(BG) Bunge - Ratings and Ratios
Oilseeds, Grains, Vegetable Oils, Flours, Sugar
BG EPS (Earnings per Share)
BG Revenue
Description: BG Bunge October 30, 2025
Bunge Limited (NYSE: BG) is a global agribusiness and food company operating through four core segments: Agribusiness, Refined & Specialty Oils, Milling, and Sugar & Bioenergy. The Agribusiness unit trades and processes oilseeds (soy, rapeseed, canola, sunflower) and grains (wheat, corn), supplying animal feed, edible oil processors, and biofuel producers. The Refined & Specialty Oils segment manufactures packaged and bulk cooking oils, margarines, renewable-diesel feedstocks, and specialty ingredients such as lecithin. The Milling segment produces wheat flours, corn-based products, whole-grain ingredients, and non-GMO blends. The Sugar & Bioenergy segment generates sugar, ethanol, and electricity from sugarcane bagasse. Founded in 1818, Bunge is headquartered in Chesterfield, Missouri.
Key recent metrics: FY 2023 revenue of $62 billion, with the Agribusiness segment contributing roughly 55 % of total sales; EBITDA margin hovering around 9 % despite volatile soybean prices; and a 2024 guidance indicating a 5-7 % increase in soy-bean procurement volumes driven by strong demand from China’s feed and biodiesel markets. The company’s exposure to commodity price cycles and global grain supply-demand fundamentals makes it a bellwether for agricultural commodity trends, while its expanding renewable-diesel feedstock business aligns with the broader shift toward low-carbon fuels.
For deeper quantitative analysis, you might explore ValueRay’s detailed model on Bunge (BG).
BG Stock Overview
| Market Cap in USD | 19,034m |
| Sub-Industry | Agricultural Products & Services |
| IPO / Inception | 2001-08-02 |
BG Stock Ratings
| Growth Rating | 21.6% |
| Fundamental | 44.2% |
| Dividend Rating | 74.8% |
| Return 12m vs S&P 500 | -4.0% |
| Analyst Rating | 3.90 of 5 |
BG Dividends
| Dividend Yield 12m | 4.40% |
| Yield on Cost 5y | 8.21% |
| Annual Growth 5y | 7.82% |
| Payout Consistency | 99.8% |
| Payout Ratio | 53.0% |
BG Growth Ratios
| Growth Correlation 3m | 45.1% |
| Growth Correlation 12m | 27.8% |
| Growth Correlation 5y | 29.2% |
| CAGR 5y | 1.24% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.03 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.08 |
| Sharpe Ratio 12m | -0.53 |
| Alpha | -2.06 |
| Beta | 0.646 |
| Volatility | 25.99% |
| Current Volume | 1112.2k |
| Average Volume 20d | 1319.5k |
| Stop Loss | 91.3 (-3.5%) |
| Signal | 0.11 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (1.38b TTM) > 0 and > 6% of Revenue (6% = 3.05b TTM) |
| FCFTA -0.02 (>2.0%) and ΔFCFTA -6.80pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 21.75% (prev 14.06%; Δ 7.69pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 1.02b <= Net Income 1.38b (YES >=105%, WARN >=100%) |
| Net Debt (5.42b) to EBITDA (2.76b) ratio: 1.97 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.07 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (136.0m) change vs 12m ago -5.02% (target <= -2.0% for YES) |
| Gross Margin 6.27% (prev 6.88%; Δ -0.61pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 183.0% (prev 228.5%; Δ -45.50pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.07 (EBITDA TTM 2.76b / Interest Expense TTM 450.0m) >= 6 (WARN >= 3) |
Altman Z'' 4.62
| (A) 0.36 = (Total Current Assets 21.45b - Total Current Liabilities 10.38b) / Total Assets 31.15b |
| (B) 0.42 = Retained Earnings (Balance) 13.01b / Total Assets 31.15b |
| (C) 0.08 = EBIT TTM 2.28b / Avg Total Assets 27.79b |
| (D) 0.36 = Book Value of Equity 6.89b / Total Liabilities 19.20b |
| Total Rating: 4.62 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 44.23
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield -2.19% = -1.10 |
| 3. FCF Margin -1.05% = -0.40 |
| 4. Debt/Equity 1.12 = 1.90 |
| 5. Debt/Ebitda 1.97 = 0.07 |
| 6. ROIC - WACC (= 4.13)% = 5.16 |
| 7. RoE 13.28% = 1.11 |
| 8. Rev. Trend -93.15% = -6.99 |
| 9. EPS Trend -80.59% = -4.03 |
What is the price of BG shares?
Over the past week, the price has changed by -3.27%, over one month by +16.43%, over three months by +19.65% and over the past year by +16.55%.
Is Bunge a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BG is around 92.49 USD . This means that BG is currently overvalued and has a potential downside of -2.23%.
Is BG a buy, sell or hold?
- Strong Buy: 4
- Buy: 1
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 99.7 | 5.4% |
| Analysts Target Price | 99.7 | 5.4% |
| ValueRay Target Price | 100.2 | 6% |
BG Fundamental Data Overview November 01, 2025
P/E Trailing = 9.5907
P/E Forward = 9.5877
P/S = 0.3742
P/B = 1.5262
P/EG = 1.7053
Beta = 0.646
Revenue TTM = 50.86b USD
EBIT TTM = 2.28b USD
EBITDA TTM = 2.76b USD
Long Term Debt = 7.04b USD (from longTermDebt, last quarter)
Short Term Debt = 4.51b USD (from shortTermDebt, last quarter)
Debt = 12.21b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.42b USD (from netDebt column, last quarter)
Enterprise Value = 24.46b USD (19.03b + Debt 12.21b - CCE 6.79b)
Interest Coverage Ratio = 5.07 (Ebit TTM 2.28b / Interest Expense TTM 450.0m)
FCF Yield = -2.19% (FCF TTM -536.0m / Enterprise Value 24.46b)
FCF Margin = -1.05% (FCF TTM -536.0m / Revenue TTM 50.86b)
Net Margin = 2.71% (Net Income TTM 1.38b / Revenue TTM 50.86b)
Gross Margin = 6.27% ((Revenue TTM 50.86b - Cost of Revenue TTM 47.67b) / Revenue TTM)
Gross Margin QoQ = 5.78% (prev 5.13%)
Tobins Q-Ratio = 0.79 (Enterprise Value 24.46b / Total Assets 31.15b)
Interest Expense / Debt = 0.87% (Interest Expense 106.0m / Debt 12.21b)
Taxrate = 25.10% (124.0m / 494.0m)
NOPAT = 1.71b (EBIT 2.28b * (1 - 25.10%))
Current Ratio = 2.07 (Total Current Assets 21.45b / Total Current Liabilities 10.38b)
Debt / Equity = 1.12 (Debt 12.21b / totalStockholderEquity, last quarter 10.88b)
Debt / EBITDA = 1.97 (Net Debt 5.42b / EBITDA 2.76b)
Debt / FCF = -10.12 (negative FCF - burning cash) (Net Debt 5.42b / FCF TTM -536.0m)
Total Stockholder Equity = 10.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.42% (Net Income 1.38b / Total Assets 31.15b)
RoE = 13.28% (Net Income TTM 1.38b / Total Stockholder Equity 10.38b)
RoCE = 13.09% (EBIT 2.28b / Capital Employed (Equity 10.38b + L.T.Debt 7.04b))
RoIC = 9.50% (NOPAT 1.71b / Invested Capital 17.98b)
WACC = 5.37% (E(19.03b)/V(31.25b) * Re(8.40%) + D(12.21b)/V(31.25b) * Rd(0.87%) * (1-Tc(0.25)))
Discount Rate = 8.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.81%
Fair Price DCF = unknown (Cash Flow -536.0m)
EPS Correlation: -80.59 | EPS CAGR: -60.95% | SUE: -3.41 | # QB: 0
Revenue Correlation: -93.15 | Revenue CAGR: -9.41% | SUE: 0.55 | # QB: 0
Additional Sources for BG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle